| Phase 01 trial |
|
Phase 0
|
NCT04637269 |
Nov 2020 → Nov 2021 |
plasma cell myeloma |
Xinqiao Hospital of Chongqing |
Unknown
|
No outcome recorded
|
| Phase 27 trials |
|
Phase 2
|
NCT06880393 |
Mar 2025 → Mar 2027 expected |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06793449 |
Feb 2025 → Dec 2026 expected |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05979363 |
Aug 2023 → Jul 2026 overdue |
plasma cell leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05846737 |
May 2023 → May 2025 |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT05870917 |
May 2023 → Jun 2026 overdue |
plasma cell leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05850286 |
Apr 2023 → Apr 2026 overdue |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05860036 |
Apr 2023 → Jun 2025 overdue |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Active not recruiting
|
No outcome recorded
|